• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Post COVID-19 burden: focus on the short-term condition.

作者信息

Yang Fengwen, Pang Bo, Jin Xinyao, Chen Zhe, Pang Wentai, Liu Qingquan, Zhang Junhua, Zhang Boli

机构信息

State Key Laboratory of Component-Based Chinese Medicine, Tianjin University of Traditional Chinese Medicine, Tianjin, China.

Haihe Laboratory of Modern Chinese Medicine, Tianjin, China.

出版信息

Acupunct Herb Med. 2022 Sep;2(3):139-142. doi: 10.1097/HM9.0000000000000036. Epub 2022 Dec 8.

DOI:10.1097/HM9.0000000000000036
PMID:37808352
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9746249/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c171/9746249/20873b3a1eb5/hm9-2-139-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c171/9746249/57b6f56ffb9d/hm9-2-139-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c171/9746249/20873b3a1eb5/hm9-2-139-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c171/9746249/57b6f56ffb9d/hm9-2-139-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c171/9746249/20873b3a1eb5/hm9-2-139-g002.jpg

相似文献

1
Post COVID-19 burden: focus on the short-term condition.新冠疫情后的负担：关注短期状况。
Acupunct Herb Med. 2022 Sep;2(3):139-142. doi: 10.1097/HM9.0000000000000036. Epub 2022 Dec 8.
2
Post-COVID Conditions and Burden of Disease.新冠后状况和疾病负担。
Phys Med Rehabil Clin N Am. 2023 Aug;34(3):499-511. doi: 10.1016/j.pmr.2023.04.007. Epub 2023 May 26.
3
COVID-19 and its sequelae: a platform for optimal patient care, discovery and training.COVID-19 及其后遗症：优化患者护理、发现和培训的平台。
J Thromb Thrombolysis. 2021 Apr;51(3):587-594. doi: 10.1007/s11239-021-02375-w. Epub 2021 Jan 27.
4
Preventing a Post-Pandemic Double Burden of Disease in the COVID-19 Pandemic.在新冠疫情中预防疫情后疾病双重负担
Glob Adv Health Med. 2021 May 3;10:21649561211010137. doi: 10.1177/21649561211010137. eCollection 2021.
5
European Working Group on SARS-CoV-2: Current Understanding, Unknowns, and Recommendations on the Neurological Complications of COVID-19.欧洲严重急性呼吸综合征冠状病毒 2 工作组：关于 COVID-19 神经系统并发症的现有认识、未知问题和建议。
Brain Connect. 2023 May;13(4):178-210. doi: 10.1089/brain.2022.0058. Epub 2023 Mar 24.
6
The Kinetics of Anti-SARS-CoV-2 Antibodies in Pediatric Patients and the Characterization of Post-COVID-19 Condition at 6 Months After Infection: Protocol for a Longitudinal Observational Study.儿童患者中抗SARS-CoV-2抗体的动力学及感染后6个月新冠后状况的特征：一项纵向观察性研究方案
JMIR Res Protoc. 2023 Jun 6;12:e43344. doi: 10.2196/43344.
7
Occupational Therapy-Based Energy Management Education in People with Post-COVID-19 Condition-Related Fatigue: Results from a Focus Group Discussion.基于职业治疗的能量管理教育在新冠后疲劳人群中的应用：一项焦点小组讨论的结果。
Occup Ther Int. 2022 Apr 14;2022:4590154. doi: 10.1155/2022/4590154. eCollection 2022.
8
Neuropsychological impairment in post-COVID condition individuals with and without cognitive complaints.有和没有认知主诉的新冠后综合征个体的神经心理学损害
Front Aging Neurosci. 2022 Oct 20;14:1029842. doi: 10.3389/fnagi.2022.1029842. eCollection 2022.
9
Post-Coronavirus Disease 2019 Pulmonary Fibrosis: Wait or Needs Intervention.2019冠状病毒病后肺纤维化：等待还是需要干预。
Tuberc Respir Dis (Seoul). 2022 Oct;85(4):320-331. doi: 10.4046/trd.2022.0053. Epub 2022 Jun 20.
10
Post-COVID Interstitial Lung Disease-The Tip of the Iceberg.新冠后间质性肺病——冰山一角。
Immunol Allergy Clin North Am. 2023 May;43(2):389-410. doi: 10.1016/j.iac.2023.01.004. Epub 2023 Mar 3.

引用本文的文献

1
COVID-19, vaccination and migraine: Causal association or epiphenomenon?COVID-19、疫苗接种和偏头痛：因果关联还是偶然现象？
PLoS One. 2024 Aug 19;19(8):e0308151. doi: 10.1371/journal.pone.0308151. eCollection 2024.
2
Top 100 cited research on COVID-19 vaccines: A bibliometric analysis and evidence mapping.100 篇高被引 COVID-19 疫苗研究：文献计量分析和证据图谱。
Hum Vaccin Immunother. 2024 Dec 31;20(1):2370605. doi: 10.1080/21645515.2024.2370605. Epub 2024 Jul 8.
3
An overview and single-arm meta-analysis of immune-mediated adverse events following COVID-19 vaccination.

本文引用的文献

1
Long COVID after breakthrough SARS-CoV-2 infection.突破性 SARS-CoV-2 感染后的长新冠。
Nat Med. 2022 Jul;28(7):1461-1467. doi: 10.1038/s41591-022-01840-0. Epub 2022 May 25.
2
Health outcomes in people 2 years after surviving hospitalisation with COVID-19: a longitudinal cohort study.COVID-19 住院幸存者 2 年后的健康结局：一项纵向队列研究。
Lancet Respir Med. 2022 Sep;10(9):863-876. doi: 10.1016/S2213-2600(22)00126-6. Epub 2022 May 11.
3
Global Prevalence of Post-Coronavirus Disease 2019 (COVID-19) Condition or Long COVID: A Meta-Analysis and Systematic Review.
新型冠状病毒肺炎疫苗接种后免疫介导不良事件的概述及单臂荟萃分析
Front Pharmacol. 2024 Jun 12;15:1308768. doi: 10.3389/fphar.2024.1308768. eCollection 2024.
4
Expert consensus on the use of traditional Chinese medicine for the treatment of common symptoms of post-COVID-19 short-term condition.中医治疗新型冠状病毒肺炎后短期常见症状的专家共识
Acupunct Herb Med. 2023 Jun;3(2):63-68. doi: 10.1097/HM9.0000000000000066. Epub 2023 Apr 27.
5
Oxalic acid blocked the binding of spike protein from SARS-CoV-2 Delta (B.1.617.2) and Omicron (B.1.1.529) variants to human angiotensin-converting enzymes 2.草酸阻断了 SARS-CoV-2 德尔塔（B.1.617.2）和奥密克戎（B.1.1.529）变异株的刺突蛋白与人血管紧张素转化酶 2 的结合。
PLoS One. 2023 May 18;18(5):e0285722. doi: 10.1371/journal.pone.0285722. eCollection 2023.
全球新型冠状病毒病 2019（COVID-19）后状况或长新冠的流行率：一项荟萃分析和系统评价。
J Infect Dis. 2022 Nov 1;226(9):1593-1607. doi: 10.1093/infdis/jiac136.
4
Qingjin Yiqi granules for post-COVID-19 condition: A randomized clinical trial.清肺益气颗粒治疗 COVID-19 后状态：一项随机临床试验。
J Evid Based Med. 2022 Mar;15(1):30-38. doi: 10.1111/jebm.12465.
5
Studying severe long COVID to understand post-infectious disorders beyond COVID-19.研究严重的长期新冠后遗症，以了解新冠病毒感染后的疾病情况。
Nat Med. 2022 May;28(5):879-882. doi: 10.1038/s41591-022-01766-7.
6
ESCMID rapid guidelines for assessment and management of long COVID.ESCMID 长新冠评估与管理快速指南。
Clin Microbiol Infect. 2022 Jul;28(7):955-972. doi: 10.1016/j.cmi.2022.02.018. Epub 2022 Feb 17.
7
Long covid: "Holistic" approach is best, given range of symptoms, say researchers.研究人员称，鉴于长新冠症状多样，“整体”疗法最为适宜。
BMJ. 2022 Feb 8;376:o336. doi: 10.1136/bmj.o336.
8
Early assessment of the clinical severity of the SARS-CoV-2 omicron variant in South Africa: a data linkage study.南非对 SARS-CoV-2 奥密克戎变异株临床严重程度的早期评估：一项数据关联研究。
Lancet. 2022 Jan 29;399(10323):437-446. doi: 10.1016/S0140-6736(22)00017-4. Epub 2022 Jan 19.
9
Shumian capsule improves symptoms of sleep mood disorder in convalescent patients of Corona Virus Disease 2019.睡眠情绪障碍在新冠病毒病 2019 恢复期患者中的应用
J Tradit Chin Med. 2021 Dec;41(6):974-981. doi: 10.19852/j.cnki.jtcm.2021.06.015.
10
Efficacy and safety of Bufei Huoxue capsules in the management of convalescent patients with COVID-19 infection: A multicentre, double-blind, and randomised controlled trial.补肺活血胶囊治疗新型冠状病毒感染后恢复期患者的有效性和安全性：一项多中心、双盲、随机对照临床试验。
J Ethnopharmacol. 2022 Feb 10;284:114830. doi: 10.1016/j.jep.2021.114830. Epub 2021 Nov 9.